CV-11974, the active metabolite of TCV-116 (candesarten), inhibits the synergistic or additive effect of different growth factors on angiotensin II-induced proliferation of vascular smooth muscle cells

Biochemical Pharmacology

Volumn 52, Issue 1, 1996, Pages 123-126

  Sachinidis, Agapios ^a   El Haschimi, Karim ^a   Ko, Yon ^a   Seul, Claudia ^a   Düsing, Rainer ^a   Vetter, Hans ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Angiotensin II; CV 11974; VSMC growth

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CANDESARTAN; CANDESARTAN HEXETIL; DRUG METABOLITE; EPIDERMAL GROWTH FACTOR; GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BB; RADIOISOTOPE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; DRUG INHIBITION; DRUG POTENTIATION; NONHUMAN; PRIORITY JOURNAL; RAT; THORACIC AORTA; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN II; ANIMALS; ANTIHYPERTENSIVE AGENTS; BENZIMIDAZOLES; BIPHENYL COMPOUNDS; CELL DIVISION; CELLS, CULTURED; DRUG SYNERGISM; EPIDERMAL GROWTH FACTOR; MUSCLE, SMOOTH, VASCULAR; PLATELET-DERIVED GROWTH FACTOR; RATS; RATS, INBRED WKY; TETRAZOLES;

EID: 0029888273     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(96)00171-2     Document Type: Article

References (14)

1. Schwartz SM and Reidy M, Common mechanisms of proliferation of smooth muscle in atherosclerosis and hypertension. Hum Pathol 18: 240-247, 1987.
2. Schwartz SM, Campbell GR and Campbell JH, Replication of smooth muscle cells in vascular disease. Circ Res 58: 427-444, 1986.
3. Ross R, The pathogenesis of atherosclerosis - an update. N Engl J Med 314: 488-500, 1986.
4. Schelling P, Fischer H and Ganten D, Angiotensin and cell growth: a link to cardiovascular hypertrophy. J Hypertens 9: 3-15, 1991.
5. Azuma H, Niimi Y and Hamasaki H, Prevention of intimal thickening after endothelial removal by a nonpeptide angiotensin I receptor antagonist, losartan. Br J Pharmacol 106: 665-671, 1992.
6. Kawamura M, Terashita Z-I, Okuda H, Imura Y, Shino A, Nakao M and Nishikawa K, TCV-116, a novel Angiotensin II receptor antagonist, prevents intima thickening and impairment of vascular function after carotic injury in rats. J Pharmacol Exp Ther 266: 1664-1669, 1993.
7. Powell J, Clozel J-P, Müller RKM, Kuhn H, Hefti F, Mosang M and Baumgartner HR, Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 245: 186-245, 1989.
8. Chamley JH, Campbell GR and Ross R, The smooth muscle cell in culture. Physiol Rev 39: 1-9, 1979.
9. Ross RJ, The smooth muscle cell II. Growth of smooth muscle in culture and formation of elastic fiber. J Cell Biol 50: 172-182, 1971.
10. Sachinidis A, Ko Y, Nettekoven W, Wieczorek AJ, Düsing R and Vetter H, The effect of angiotensin II on DNA synthesis varies considerably in vascular smooth muscle cells from different Wistar-Kyoto rats. J Hypertension 10: 1159-1164, 1992.
11. Timmermanns PBMWM, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye AM and Smith R, Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 45: 205-251, 1993.
12. Geisterfer ATT, Peach MJ and Owence GK, Angiotensin II induces hypertrophy, not hyperplasia, of cultured smooth muscle cells. Circ Res 62: 749-756, 1988.
13. Berk BC, Vekshtein V, Gordon HM and Tsuda T, Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension 13: 305-314, 1989.
14. Daemen MJAP, Lombardi DM, Bosman FT and Schwartz SM, Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res 68: 450-456, 1991.